nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—CYP2C19—Desloratadine—allergic rhinitis	0.0475	0.0717	CbGbCtD
Gefitinib—CYP2C9—Desloratadine—allergic rhinitis	0.0395	0.0596	CbGbCtD
Gefitinib—ABCB1—Desloratadine—allergic rhinitis	0.0383	0.0578	CbGbCtD
Gefitinib—CYP2D6—Desloratadine—allergic rhinitis	0.0361	0.0545	CbGbCtD
Gefitinib—ABCG2—Hydrocortisone—allergic rhinitis	0.034	0.0512	CbGbCtD
Gefitinib—CYP2C19—Loratadine—allergic rhinitis	0.0273	0.0412	CbGbCtD
Gefitinib—CYP2C19—Diphenhydramine—allergic rhinitis	0.0273	0.0412	CbGbCtD
Gefitinib—CYP3A4—Flunisolide—allergic rhinitis	0.023	0.0347	CbGbCtD
Gefitinib—CYP2C9—Loratadine—allergic rhinitis	0.0227	0.0342	CbGbCtD
Gefitinib—CYP2C9—Montelukast—allergic rhinitis	0.0227	0.0342	CbGbCtD
Gefitinib—CYP2C9—Diphenhydramine—allergic rhinitis	0.0227	0.0342	CbGbCtD
Gefitinib—ABCB1—Loratadine—allergic rhinitis	0.022	0.0332	CbGbCtD
Gefitinib—CYP3A4—Olopatadine—allergic rhinitis	0.0216	0.0326	CbGbCtD
Gefitinib—ABCG2—Dexamethasone—allergic rhinitis	0.0211	0.0319	CbGbCtD
Gefitinib—CYP2D6—Loratadine—allergic rhinitis	0.0207	0.0313	CbGbCtD
Gefitinib—CYP2D6—Diphenhydramine—allergic rhinitis	0.0207	0.0313	CbGbCtD
Gefitinib—ABCB1—Methylprednisolone—allergic rhinitis	0.0201	0.0304	CbGbCtD
Gefitinib—CYP1A1—Dexamethasone—allergic rhinitis	0.0195	0.0294	CbGbCtD
Gefitinib—CYP3A5—Hydrocortisone—allergic rhinitis	0.0188	0.0284	CbGbCtD
Gefitinib—CYP3A4—Loratadine—allergic rhinitis	0.0132	0.0199	CbGbCtD
Gefitinib—CYP3A4—Montelukast—allergic rhinitis	0.0132	0.0199	CbGbCtD
Gefitinib—ABCB1—Betamethasone—allergic rhinitis	0.0131	0.0198	CbGbCtD
Gefitinib—ABCB1—Prednisolone—allergic rhinitis	0.0129	0.0195	CbGbCtD
Gefitinib—ABCB1—Hydrocortisone—allergic rhinitis	0.0122	0.0185	CbGbCtD
Gefitinib—CYP3A4—Methylprednisolone—allergic rhinitis	0.0121	0.0182	CbGbCtD
Gefitinib—CYP3A5—Dexamethasone—allergic rhinitis	0.0117	0.0177	CbGbCtD
Gefitinib—CYP2C19—Dexamethasone—allergic rhinitis	0.00944	0.0142	CbGbCtD
Gefitinib—CYP3A4—Triamcinolone—allergic rhinitis	0.00914	0.0138	CbGbCtD
Gefitinib—CYP2C9—Dexamethasone—allergic rhinitis	0.00784	0.0118	CbGbCtD
Gefitinib—CYP3A4—Betamethasone—allergic rhinitis	0.00784	0.0118	CbGbCtD
Gefitinib—CYP3A4—Prednisolone—allergic rhinitis	0.00774	0.0117	CbGbCtD
Gefitinib—ABCB1—Dexamethasone—allergic rhinitis	0.00761	0.0115	CbGbCtD
Gefitinib—CYP3A4—Hydrocortisone—allergic rhinitis	0.00733	0.0111	CbGbCtD
Gefitinib—CYP2D6—Dexamethasone—allergic rhinitis	0.00717	0.0108	CbGbCtD
Gefitinib—ORM1—saliva—allergic rhinitis	0.00523	0.0634	CbGeAlD
Gefitinib—ERBB3—exocrine gland—allergic rhinitis	0.00472	0.0572	CbGeAlD
Gefitinib—CYP3A4—Dexamethasone—allergic rhinitis	0.00456	0.00688	CbGbCtD
Gefitinib—SBK1—eye—allergic rhinitis	0.00421	0.0511	CbGeAlD
Gefitinib—MAP3K19—respiratory system—allergic rhinitis	0.00327	0.0397	CbGeAlD
Gefitinib—CSNK1E—respiratory system—allergic rhinitis	0.00255	0.0309	CbGeAlD
Gefitinib—ERBB3—respiratory system—allergic rhinitis	0.00246	0.0298	CbGeAlD
Gefitinib—MKNK2—respiratory system—allergic rhinitis	0.00234	0.0283	CbGeAlD
Gefitinib—MKNK2—eye—allergic rhinitis	0.00213	0.0259	CbGeAlD
Gefitinib—CHEK2—lung—allergic rhinitis	0.00213	0.0259	CbGeAlD
Gefitinib—MKNK1—eye—allergic rhinitis	0.00211	0.0256	CbGeAlD
Gefitinib—CSNK1E—bronchus—allergic rhinitis	0.0021	0.0254	CbGeAlD
Gefitinib—IRAK4—bronchus—allergic rhinitis	0.00206	0.025	CbGeAlD
Gefitinib—ERBB3—epithelium—allergic rhinitis	0.00205	0.0249	CbGeAlD
Gefitinib—CSNK1E—skin of body—allergic rhinitis	0.00202	0.0245	CbGeAlD
Gefitinib—ERBB3—skin of body—allergic rhinitis	0.00195	0.0237	CbGeAlD
Gefitinib—MKNK2—epithelium—allergic rhinitis	0.00195	0.0237	CbGeAlD
Gefitinib—MKNK2—bronchus—allergic rhinitis	0.00192	0.0233	CbGeAlD
Gefitinib—IRAK1—bronchus—allergic rhinitis	0.00192	0.0233	CbGeAlD
Gefitinib—STK10—respiratory system—allergic rhinitis	0.0019	0.023	CbGeAlD
Gefitinib—MKNK1—bronchus—allergic rhinitis	0.0019	0.023	CbGeAlD
Gefitinib—CSNK1E—trachea—allergic rhinitis	0.00188	0.0228	CbGeAlD
Gefitinib—IRAK4—trachea—allergic rhinitis	0.00185	0.0225	CbGeAlD
Gefitinib—ERBB3—trachea—allergic rhinitis	0.00182	0.022	CbGeAlD
Gefitinib—MAP3K19—lung—allergic rhinitis	0.00174	0.0211	CbGeAlD
Gefitinib—MKNK2—trachea—allergic rhinitis	0.00173	0.0209	CbGeAlD
Gefitinib—STK10—bronchus—allergic rhinitis	0.00156	0.019	CbGeAlD
Gefitinib—EGFR—lung—allergic rhinitis	0.00141	0.017	CbGeAlD
Gefitinib—MAP2K5—bronchus—allergic rhinitis	0.0014	0.0169	CbGeAlD
Gefitinib—CSNK1E—lung—allergic rhinitis	0.00135	0.0164	CbGeAlD
Gefitinib—IRAK4—lung—allergic rhinitis	0.00133	0.0161	CbGeAlD
Gefitinib—ERBB3—lung—allergic rhinitis	0.0013	0.0158	CbGeAlD
Gefitinib—MAP2K5—trachea—allergic rhinitis	0.00125	0.0152	CbGeAlD
Gefitinib—MKNK2—lung—allergic rhinitis	0.00124	0.015	CbGeAlD
Gefitinib—IRAK1—lung—allergic rhinitis	0.00124	0.015	CbGeAlD
Gefitinib—MKNK1—lung—allergic rhinitis	0.00122	0.0148	CbGeAlD
Gefitinib—STK10—lung—allergic rhinitis	0.00101	0.0122	CbGeAlD
Gefitinib—MAP2K5—lung—allergic rhinitis	0.000901	0.0109	CbGeAlD
Gefitinib—CYP1A1—respiratory system—allergic rhinitis	0.000783	0.0095	CbGeAlD
Gefitinib—CYP3A5—respiratory system—allergic rhinitis	0.000766	0.00929	CbGeAlD
Gefitinib—ORM1—lung—allergic rhinitis	0.000731	0.00887	CbGeAlD
Gefitinib—CYP1A1—epithelium—allergic rhinitis	0.000655	0.00794	CbGeAlD
Gefitinib—CYP1A1—bronchus—allergic rhinitis	0.000645	0.00782	CbGeAlD
Gefitinib—CYP1A1—skin of body—allergic rhinitis	0.000623	0.00755	CbGeAlD
Gefitinib—CYP1A1—trachea—allergic rhinitis	0.000579	0.00702	CbGeAlD
Gefitinib—CSNK1E—Betamethasone—Flunisolide—allergic rhinitis	0.000552	0.109	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Flunisolide—allergic rhinitis	0.000552	0.109	CbGdCrCtD
Gefitinib—CSNK1E—Danazol—Hydrocortisone—allergic rhinitis	0.000448	0.0883	CbGdCrCtD
Gefitinib—ABCG2—lung—allergic rhinitis	0.000438	0.00531	CbGeAlD
Gefitinib—CYP1A1—lung—allergic rhinitis	0.000416	0.00504	CbGeAlD
Gefitinib—ABCB1—respiratory system—allergic rhinitis	0.000407	0.00493	CbGeAlD
Gefitinib—CYP3A5—lung—allergic rhinitis	0.000407	0.00493	CbGeAlD
Gefitinib—Vomiting—Dimenhydrinate—allergic rhinitis	0.00037	0.00184	CcSEcCtD
Gefitinib—Vomiting—Diphenhydramine—allergic rhinitis	0.00037	0.00184	CcSEcCtD
Gefitinib—Dyspnoea—Flunisolide—allergic rhinitis	0.000369	0.00184	CcSEcCtD
Gefitinib—Eye pain—Betamethasone—allergic rhinitis	0.000367	0.00183	CcSEcCtD
Gefitinib—Eye pain—Dexamethasone—allergic rhinitis	0.000367	0.00183	CcSEcCtD
Gefitinib—Rash—Dimenhydrinate—allergic rhinitis	0.000367	0.00182	CcSEcCtD
Gefitinib—Rash—Diphenhydramine—allergic rhinitis	0.000367	0.00182	CcSEcCtD
Gefitinib—Decreased appetite—Cetirizine—allergic rhinitis	0.000366	0.00182	CcSEcCtD
Gefitinib—Dermatitis—Dimenhydrinate—allergic rhinitis	0.000366	0.00182	CcSEcCtD
Gefitinib—Dermatitis—Diphenhydramine—allergic rhinitis	0.000366	0.00182	CcSEcCtD
Gefitinib—Gastrointestinal pain—Loratadine—allergic rhinitis	0.000366	0.00182	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.000366	0.00182	CcSEcCtD
Gefitinib—Dry skin—Prednisolone—allergic rhinitis	0.000364	0.00181	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000364	0.00181	CcSEcCtD
Gefitinib—Fatigue—Cetirizine—allergic rhinitis	0.000363	0.00181	CcSEcCtD
Gefitinib—Pain—Cetirizine—allergic rhinitis	0.00036	0.00179	CcSEcCtD
Gefitinib—Constipation—Cetirizine—allergic rhinitis	0.00036	0.00179	CcSEcCtD
Gefitinib—Decreased appetite—Flunisolide—allergic rhinitis	0.00036	0.00179	CcSEcCtD
Gefitinib—Fatigue—Flunisolide—allergic rhinitis	0.000357	0.00178	CcSEcCtD
Gefitinib—Dry skin—Hydrocortisone—allergic rhinitis	0.000356	0.00177	CcSEcCtD
Gefitinib—Pain—Flunisolide—allergic rhinitis	0.000354	0.00176	CcSEcCtD
Gefitinib—Constipation—Flunisolide—allergic rhinitis	0.000354	0.00176	CcSEcCtD
Gefitinib—Abdominal pain—Loratadine—allergic rhinitis	0.000354	0.00176	CcSEcCtD
Gefitinib—Body temperature increased—Loratadine—allergic rhinitis	0.000354	0.00176	CcSEcCtD
Gefitinib—Hypokalaemia—Hydrocortisone—allergic rhinitis	0.000353	0.00176	CcSEcCtD
Gefitinib—Nausea—Olopatadine—allergic rhinitis	0.000353	0.00176	CcSEcCtD
Gefitinib—Infection—Montelukast—allergic rhinitis	0.000351	0.00175	CcSEcCtD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000349	0.00714	CbGpPWpGaD
Gefitinib—Dermatitis bullous—Dexamethasone—allergic rhinitis	0.000347	0.00173	CcSEcCtD
Gefitinib—Dermatitis bullous—Betamethasone—allergic rhinitis	0.000347	0.00173	CcSEcCtD
Gefitinib—Nervous system disorder—Montelukast—allergic rhinitis	0.000347	0.00172	CcSEcCtD
Gefitinib—Thrombocytopenia—Montelukast—allergic rhinitis	0.000346	0.00172	CcSEcCtD
Gefitinib—Nausea—Diphenhydramine—allergic rhinitis	0.000345	0.00172	CcSEcCtD
Gefitinib—Nausea—Dimenhydrinate—allergic rhinitis	0.000345	0.00172	CcSEcCtD
Gefitinib—Gastrointestinal pain—Cetirizine—allergic rhinitis	0.000345	0.00171	CcSEcCtD
Gefitinib—Skin disorder—Montelukast—allergic rhinitis	0.000343	0.00171	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Hydrocortisone—allergic rhinitis	0.000342	0.0017	CcSEcCtD
Gefitinib—ABCB1—epithelium—allergic rhinitis	0.00034	0.00412	CbGeAlD
Gefitinib—Gastrointestinal pain—Flunisolide—allergic rhinitis	0.000339	0.00169	CcSEcCtD
Gefitinib—IRAK1—Signaling by Interleukins—IL5—allergic rhinitis	0.000338	0.0069	CbGpPWpGaD
Gefitinib—Pancreatitis—Prednisolone—allergic rhinitis	0.000337	0.00168	CcSEcCtD
Gefitinib—Urticaria—Cetirizine—allergic rhinitis	0.000335	0.00167	CcSEcCtD
Gefitinib—Body temperature increased—Cetirizine—allergic rhinitis	0.000333	0.00166	CcSEcCtD
Gefitinib—Abdominal pain—Cetirizine—allergic rhinitis	0.000333	0.00166	CcSEcCtD
Gefitinib—Urticaria—Flunisolide—allergic rhinitis	0.000329	0.00164	CcSEcCtD
Gefitinib—Pancreatitis—Hydrocortisone—allergic rhinitis	0.000329	0.00164	CcSEcCtD
Gefitinib—Body temperature increased—Flunisolide—allergic rhinitis	0.000328	0.00163	CcSEcCtD
Gefitinib—Abdominal pain—Flunisolide—allergic rhinitis	0.000328	0.00163	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Methylprednisolone—allergic rhinitis	0.000322	0.0016	CcSEcCtD
Gefitinib—Asthenia—Loratadine—allergic rhinitis	0.000321	0.0016	CcSEcCtD
Gefitinib—CSNK1E—Circadian rythm related genes—ADIPOQ—allergic rhinitis	0.000314	0.00641	CbGpPWpGaD
Gefitinib—IRAK4—IL-1 signaling pathway—NFKB1—allergic rhinitis	0.000312	0.00638	CbGpPWpGaD
Gefitinib—Hypersensitivity—Cetirizine—allergic rhinitis	0.00031	0.00154	CcSEcCtD
Gefitinib—Pancreatitis—Triamcinolone—allergic rhinitis	0.00031	0.00154	CcSEcCtD
Gefitinib—Pancreatitis—Methylprednisolone—allergic rhinitis	0.000309	0.00154	CcSEcCtD
Gefitinib—Diarrhoea—Loratadine—allergic rhinitis	0.000306	0.00152	CcSEcCtD
Gefitinib—IRAK4—Innate Immune System—MS4A2—allergic rhinitis	0.000306	0.00625	CbGpPWpGaD
Gefitinib—Hypersensitivity—Flunisolide—allergic rhinitis	0.000305	0.00152	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000305	0.00152	CcSEcCtD
Gefitinib—Fatigue—Montelukast—allergic rhinitis	0.000305	0.00152	CcSEcCtD
Gefitinib—IRAK1—IL1-mediated signaling events—NFKB1—allergic rhinitis	0.000304	0.00623	CbGpPWpGaD
Gefitinib—Dry skin—Dexamethasone—allergic rhinitis	0.000304	0.00151	CcSEcCtD
Gefitinib—Dry skin—Betamethasone—allergic rhinitis	0.000304	0.00151	CcSEcCtD
Gefitinib—Weight decreased—Hydrocortisone—allergic rhinitis	0.000304	0.00151	CcSEcCtD
Gefitinib—Asthenia—Cetirizine—allergic rhinitis	0.000302	0.0015	CcSEcCtD
Gefitinib—Pain—Montelukast—allergic rhinitis	0.000302	0.0015	CcSEcCtD
Gefitinib—Hypokalaemia—Betamethasone—allergic rhinitis	0.000302	0.0015	CcSEcCtD
Gefitinib—Hypokalaemia—Dexamethasone—allergic rhinitis	0.000302	0.0015	CcSEcCtD
Gefitinib—ABCB1—trachea—allergic rhinitis	0.000301	0.00365	CbGeAlD
Gefitinib—Infestation NOS—Hydrocortisone—allergic rhinitis	0.000299	0.00149	CcSEcCtD
Gefitinib—Infestation—Hydrocortisone—allergic rhinitis	0.000299	0.00149	CcSEcCtD
Gefitinib—Pruritus—Cetirizine—allergic rhinitis	0.000298	0.00148	CcSEcCtD
Gefitinib—Conjunctivitis—Prednisolone—allergic rhinitis	0.000298	0.00148	CcSEcCtD
Gefitinib—Asthenia—Flunisolide—allergic rhinitis	0.000297	0.00148	CcSEcCtD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.000294	0.00602	CbGpPWpGaD
Gefitinib—Pruritus—Flunisolide—allergic rhinitis	0.000293	0.00146	CcSEcCtD
Gefitinib—Gastrointestinal pain—Montelukast—allergic rhinitis	0.000289	0.00144	CcSEcCtD
Gefitinib—Diarrhoea—Cetirizine—allergic rhinitis	0.000288	0.00143	CcSEcCtD
Gefitinib—CSNK1E—Betamethasone—Hydrocortisone—allergic rhinitis	0.000286	0.0564	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Hydrocortisone—allergic rhinitis	0.000286	0.0564	CbGdCrCtD
Gefitinib—Vomiting—Loratadine—allergic rhinitis	0.000285	0.00142	CcSEcCtD
Gefitinib—Diarrhoea—Flunisolide—allergic rhinitis	0.000283	0.00141	CcSEcCtD
Gefitinib—Rash—Loratadine—allergic rhinitis	0.000282	0.0014	CcSEcCtD
Gefitinib—Dermatitis—Loratadine—allergic rhinitis	0.000282	0.0014	CcSEcCtD
Gefitinib—Infestation—Methylprednisolone—allergic rhinitis	0.000281	0.0014	CcSEcCtD
Gefitinib—Infestation NOS—Methylprednisolone—allergic rhinitis	0.000281	0.0014	CcSEcCtD
Gefitinib—Urticaria—Montelukast—allergic rhinitis	0.000281	0.0014	CcSEcCtD
Gefitinib—Abdominal pain—Montelukast—allergic rhinitis	0.000279	0.00139	CcSEcCtD
Gefitinib—Body temperature increased—Montelukast—allergic rhinitis	0.000279	0.00139	CcSEcCtD
Gefitinib—Haemoglobin—Prednisolone—allergic rhinitis	0.000276	0.00138	CcSEcCtD
Gefitinib—CHEK2—Testosterone Propionate—Hydrocortisone—allergic rhinitis	0.000276	0.0544	CbGdCrCtD
Gefitinib—Haemorrhage—Prednisolone—allergic rhinitis	0.000275	0.00137	CcSEcCtD
Gefitinib—Conjunctivitis—Triamcinolone—allergic rhinitis	0.000274	0.00136	CcSEcCtD
Gefitinib—CSNK1E—Betamethasone—Methylprednisolone—allergic rhinitis	0.00027	0.0532	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Methylprednisolone—allergic rhinitis	0.00027	0.0532	CbGdCrCtD
Gefitinib—Haemoglobin—Hydrocortisone—allergic rhinitis	0.00027	0.00134	CcSEcCtD
Gefitinib—IRAK4—AGE/RAGE pathway—NFKB1—allergic rhinitis	0.00027	0.00552	CbGpPWpGaD
Gefitinib—Haemorrhage—Hydrocortisone—allergic rhinitis	0.000269	0.00134	CcSEcCtD
Gefitinib—Vomiting—Cetirizine—allergic rhinitis	0.000268	0.00133	CcSEcCtD
Gefitinib—EGFR—Developmental Biology—PFN2—allergic rhinitis	0.000268	0.00547	CbGpPWpGaD
Gefitinib—IRAK1—Interleukin-1 signaling—NFKB1—allergic rhinitis	0.000267	0.00547	CbGpPWpGaD
Gefitinib—Nausea—Loratadine—allergic rhinitis	0.000266	0.00132	CcSEcCtD
Gefitinib—CSNK1E—Dexamethasone—Betamethasone—allergic rhinitis	0.000266	0.0524	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Dexamethasone—allergic rhinitis	0.000266	0.0524	CbGdCrCtD
Gefitinib—Epistaxis—Triamcinolone—allergic rhinitis	0.000266	0.00132	CcSEcCtD
Gefitinib—Rash—Cetirizine—allergic rhinitis	0.000266	0.00132	CcSEcCtD
Gefitinib—Dermatitis—Cetirizine—allergic rhinitis	0.000265	0.00132	CcSEcCtD
Gefitinib—Vomiting—Flunisolide—allergic rhinitis	0.000263	0.00131	CcSEcCtD
Gefitinib—Rash—Flunisolide—allergic rhinitis	0.000261	0.0013	CcSEcCtD
Gefitinib—Dermatitis—Flunisolide—allergic rhinitis	0.000261	0.0013	CcSEcCtD
Gefitinib—Hypersensitivity—Montelukast—allergic rhinitis	0.00026	0.0013	CcSEcCtD
Gefitinib—CSNK1E—Betamethasone—Triamcinolone—allergic rhinitis	0.00026	0.0512	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Triamcinolone—allergic rhinitis	0.00026	0.0512	CbGdCrCtD
Gefitinib—Weight decreased—Betamethasone—allergic rhinitis	0.000259	0.00129	CcSEcCtD
Gefitinib—Weight decreased—Dexamethasone—allergic rhinitis	0.000259	0.00129	CcSEcCtD
Gefitinib—MAP2K5—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000258	0.00528	CbGpPWpGaD
Gefitinib—ERBB3—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—allergic rhinitis	0.000256	0.00524	CbGpPWpGaD
Gefitinib—Haemoglobin—Triamcinolone—allergic rhinitis	0.000254	0.00126	CcSEcCtD
Gefitinib—Haemoglobin—Methylprednisolone—allergic rhinitis	0.000254	0.00126	CcSEcCtD
Gefitinib—Asthenia—Montelukast—allergic rhinitis	0.000254	0.00126	CcSEcCtD
Gefitinib—Haemorrhage—Triamcinolone—allergic rhinitis	0.000253	0.00126	CcSEcCtD
Gefitinib—Haemorrhage—Methylprednisolone—allergic rhinitis	0.000252	0.00126	CcSEcCtD
Gefitinib—Eye disorder—Hydrocortisone—allergic rhinitis	0.000251	0.00125	CcSEcCtD
Gefitinib—Nausea—Cetirizine—allergic rhinitis	0.00025	0.00125	CcSEcCtD
Gefitinib—Pruritus—Montelukast—allergic rhinitis	0.00025	0.00124	CcSEcCtD
Gefitinib—Conjunctivitis—Dexamethasone—allergic rhinitis	0.000248	0.00124	CcSEcCtD
Gefitinib—Conjunctivitis—Betamethasone—allergic rhinitis	0.000248	0.00124	CcSEcCtD
Gefitinib—Nausea—Flunisolide—allergic rhinitis	0.000246	0.00122	CcSEcCtD
Gefitinib—Arrhythmia—Prednisolone—allergic rhinitis	0.000246	0.00122	CcSEcCtD
Gefitinib—ERBB3—Innate Immune System—MS4A2—allergic rhinitis	0.000244	0.00499	CbGpPWpGaD
Gefitinib—Diarrhoea—Montelukast—allergic rhinitis	0.000242	0.0012	CcSEcCtD
Gefitinib—CSNK1E—Betamethasone—Prednisolone—allergic rhinitis	0.000241	0.0474	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Prednisolone—allergic rhinitis	0.000241	0.0474	CbGdCrCtD
Gefitinib—Arrhythmia—Hydrocortisone—allergic rhinitis	0.00024	0.00119	CcSEcCtD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000237	0.00485	CbGpPWpGaD
Gefitinib—Eye disorder—Methylprednisolone—allergic rhinitis	0.000236	0.00117	CcSEcCtD
Gefitinib—EGFR—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.000236	0.00482	CbGpPWpGaD
Gefitinib—IRAK1—Structural Pathway of Interleukin 1 (IL-1)—NFKB1—allergic rhinitis	0.000235	0.00481	CbGpPWpGaD
Gefitinib—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000234	0.00117	CcSEcCtD
Gefitinib—Malnutrition—Hydrocortisone—allergic rhinitis	0.000234	0.00116	CcSEcCtD
Gefitinib—Haemoglobin—Betamethasone—allergic rhinitis	0.000231	0.00115	CcSEcCtD
Gefitinib—Haemoglobin—Dexamethasone—allergic rhinitis	0.000231	0.00115	CcSEcCtD
Gefitinib—EGFR—Regulation of Telomerase—SMAD3—allergic rhinitis	0.00023	0.0047	CbGpPWpGaD
Gefitinib—Haemorrhage—Betamethasone—allergic rhinitis	0.000229	0.00114	CcSEcCtD
Gefitinib—Haemorrhage—Dexamethasone—allergic rhinitis	0.000229	0.00114	CcSEcCtD
Gefitinib—CHEK2—Danazol—Hydrocortisone—allergic rhinitis	0.000229	0.0452	CbGdCrCtD
Gefitinib—Angiopathy—Methylprednisolone—allergic rhinitis	0.000229	0.00114	CcSEcCtD
Gefitinib—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000227	0.00113	CcSEcCtD
Gefitinib—Arrhythmia—Triamcinolone—allergic rhinitis	0.000226	0.00112	CcSEcCtD
Gefitinib—Arrhythmia—Methylprednisolone—allergic rhinitis	0.000225	0.00112	CcSEcCtD
Gefitinib—Vomiting—Montelukast—allergic rhinitis	0.000225	0.00112	CcSEcCtD
Gefitinib—IRAK1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NFKB1—allergic rhinitis	0.000224	0.00457	CbGpPWpGaD
Gefitinib—Rash—Montelukast—allergic rhinitis	0.000223	0.00111	CcSEcCtD
Gefitinib—Dermatitis—Montelukast—allergic rhinitis	0.000223	0.00111	CcSEcCtD
Gefitinib—IRAK4—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.00022	0.00451	CbGpPWpGaD
Gefitinib—ABCG2—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.00022	0.0045	CbGpPWpGaD
Gefitinib—Malnutrition—Methylprednisolone—allergic rhinitis	0.00022	0.00109	CcSEcCtD
Gefitinib—Angioedema—Prednisolone—allergic rhinitis	0.000219	0.00109	CcSEcCtD
Gefitinib—IRAK4—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	0.000218	0.00446	CbGpPWpGaD
Gefitinib—ABCB1—lung—allergic rhinitis	0.000216	0.00262	CbGeAlD
Gefitinib—Malaise—Prednisolone—allergic rhinitis	0.000216	0.00107	CcSEcCtD
Gefitinib—EGFR—Thromboxane A2 receptor signaling—ICAM1—allergic rhinitis	0.000216	0.00441	CbGpPWpGaD
Gefitinib—MAP2K5—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000215	0.0044	CbGpPWpGaD
Gefitinib—Eye disorder—Betamethasone—allergic rhinitis	0.000214	0.00107	CcSEcCtD
Gefitinib—Eye disorder—Dexamethasone—allergic rhinitis	0.000214	0.00107	CcSEcCtD
Gefitinib—IRAK4—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	0.000214	0.00438	CbGpPWpGaD
Gefitinib—Angioedema—Hydrocortisone—allergic rhinitis	0.000214	0.00106	CcSEcCtD
Gefitinib—Malaise—Hydrocortisone—allergic rhinitis	0.000211	0.00105	CcSEcCtD
Gefitinib—Nausea—Montelukast—allergic rhinitis	0.00021	0.00104	CcSEcCtD
Gefitinib—Angiopathy—Dexamethasone—allergic rhinitis	0.000208	0.00104	CcSEcCtD
Gefitinib—Angiopathy—Betamethasone—allergic rhinitis	0.000208	0.00104	CcSEcCtD
Gefitinib—IRAK1—IL-1 signaling pathway—NFKB1—allergic rhinitis	0.000207	0.00424	CbGpPWpGaD
Gefitinib—IRAK4—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	0.000207	0.00423	CbGpPWpGaD
Gefitinib—CHEK2—Norethindrone—Hydrocortisone—allergic rhinitis	0.000207	0.0408	CbGdCrCtD
Gefitinib—Arrhythmia—Dexamethasone—allergic rhinitis	0.000205	0.00102	CcSEcCtD
Gefitinib—Arrhythmia—Betamethasone—allergic rhinitis	0.000205	0.00102	CcSEcCtD
Gefitinib—IRAK4—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000203	0.00416	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—MS4A2—allergic rhinitis	0.000203	0.00415	CbGpPWpGaD
Gefitinib—Alopecia—Betamethasone—allergic rhinitis	0.000203	0.00101	CcSEcCtD
Gefitinib—Alopecia—Dexamethasone—allergic rhinitis	0.000203	0.00101	CcSEcCtD
Gefitinib—Angioedema—Triamcinolone—allergic rhinitis	0.000201	0.001	CcSEcCtD
Gefitinib—Angioedema—Methylprednisolone—allergic rhinitis	0.000201	0.000999	CcSEcCtD
Gefitinib—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	0.0002	0.00409	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.000199	0.00408	CbGpPWpGaD
Gefitinib—Malaise—Triamcinolone—allergic rhinitis	0.000199	0.000988	CcSEcCtD
Gefitinib—Malaise—Methylprednisolone—allergic rhinitis	0.000198	0.000986	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000198	0.000984	CcSEcCtD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.000195	0.004	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle—TGFB1—allergic rhinitis	0.000194	0.00396	CbGpPWpGaD
Gefitinib—Shock—Prednisolone—allergic rhinitis	0.000192	0.000956	CcSEcCtD
Gefitinib—Cough—Triamcinolone—allergic rhinitis	0.000192	0.000956	CcSEcCtD
Gefitinib—IRAK4—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.00019	0.0039	CbGpPWpGaD
Gefitinib—Infection—Hydrocortisone—allergic rhinitis	0.00019	0.000943	CcSEcCtD
Gefitinib—Shock—Hydrocortisone—allergic rhinitis	0.000188	0.000934	CcSEcCtD
Gefitinib—EGFR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—allergic rhinitis	0.000187	0.00383	CbGpPWpGaD
Gefitinib—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000187	0.000931	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000186	0.000924	CcSEcCtD
Gefitinib—EGFR—Androgen receptor signaling pathway—SMAD3—allergic rhinitis	0.000185	0.00379	CbGpPWpGaD
Gefitinib—Skin disorder—Hydrocortisone—allergic rhinitis	0.000185	0.000922	CcSEcCtD
Gefitinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	0.000184	0.00376	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.000184	0.00376	CbGpPWpGaD
Gefitinib—Dry mouth—Triamcinolone—allergic rhinitis	0.000183	0.000912	CcSEcCtD
Gefitinib—Angioedema—Dexamethasone—allergic rhinitis	0.000183	0.000908	CcSEcCtD
Gefitinib—Angioedema—Betamethasone—allergic rhinitis	0.000183	0.000908	CcSEcCtD
Gefitinib—IRAK4—Signaling by Interleukins—NFKB1—allergic rhinitis	0.000182	0.00372	CbGpPWpGaD
Gefitinib—Anorexia—Hydrocortisone—allergic rhinitis	0.000182	0.000905	CcSEcCtD
Gefitinib—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	0.000182	0.00371	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—ADIPOQ—allergic rhinitis	0.000181	0.0037	CbGpPWpGaD
Gefitinib—Malaise—Dexamethasone—allergic rhinitis	0.00018	0.000896	CcSEcCtD
Gefitinib—Malaise—Betamethasone—allergic rhinitis	0.00018	0.000896	CcSEcCtD
Gefitinib—Infection—Triamcinolone—allergic rhinitis	0.000178	0.000888	CcSEcCtD
Gefitinib—Hypotension—Hydrocortisone—allergic rhinitis	0.000178	0.000887	CcSEcCtD
Gefitinib—Infection—Methylprednisolone—allergic rhinitis	0.000178	0.000886	CcSEcCtD
Gefitinib—IRAK4—Immune System—MS4A2—allergic rhinitis	0.000178	0.00364	CbGpPWpGaD
Gefitinib—Shock—Triamcinolone—allergic rhinitis	0.000177	0.000879	CcSEcCtD
Gefitinib—Shock—Methylprednisolone—allergic rhinitis	0.000176	0.000878	CcSEcCtD
Gefitinib—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000176	0.000875	CcSEcCtD
Gefitinib—IRAK4—Activated TLR4 signalling—NFKB1—allergic rhinitis	0.000175	0.00359	CbGpPWpGaD
Gefitinib—Skin disorder—Methylprednisolone—allergic rhinitis	0.000174	0.000866	CcSEcCtD
Gefitinib—EGFR—Hair Follicle Development: Induction (Part 1 of 3)—NFKB1—allergic rhinitis	0.000172	0.00352	CbGpPWpGaD
Gefitinib—MKNK1—MAPK Signaling Pathway—NFKB1—allergic rhinitis	0.000172	0.00352	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—IL13—allergic rhinitis	0.000171	0.0035	CbGpPWpGaD
Gefitinib—CHEK2—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	0.00017	0.00347	CbGpPWpGaD
Gefitinib—Hypotension—Methylprednisolone—allergic rhinitis	0.000168	0.000833	CcSEcCtD
Gefitinib—Pain—Prednisolone—allergic rhinitis	0.000167	0.000831	CcSEcCtD
Gefitinib—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000166	0.000825	CcSEcCtD
Gefitinib—IRAK4—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	0.000165	0.00338	CbGpPWpGaD
Gefitinib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000165	0.00082	CcSEcCtD
Gefitinib—Fatigue—Hydrocortisone—allergic rhinitis	0.000165	0.000818	CcSEcCtD
Gefitinib—CHEK2—Levonorgestrel—Hydrocortisone—allergic rhinitis	0.000165	0.0324	CbGdCrCtD
Gefitinib—Pain—Hydrocortisone—allergic rhinitis	0.000163	0.000812	CcSEcCtD
Gefitinib—Infection—Dexamethasone—allergic rhinitis	0.000162	0.000806	CcSEcCtD
Gefitinib—Infection—Betamethasone—allergic rhinitis	0.000162	0.000806	CcSEcCtD
Gefitinib—IRAK1—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—allergic rhinitis	0.000162	0.00331	CbGpPWpGaD
Gefitinib—Shock—Dexamethasone—allergic rhinitis	0.00016	0.000798	CcSEcCtD
Gefitinib—Shock—Betamethasone—allergic rhinitis	0.00016	0.000798	CcSEcCtD
Gefitinib—Dyspnoea—Triamcinolone—allergic rhinitis	0.00016	0.000797	CcSEcCtD
Gefitinib—Nervous system disorder—Betamethasone—allergic rhinitis	0.00016	0.000795	CcSEcCtD
Gefitinib—Nervous system disorder—Dexamethasone—allergic rhinitis	0.00016	0.000795	CcSEcCtD
Gefitinib—EGFR—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.00016	0.00327	CbGpPWpGaD
Gefitinib—Thrombocytopenia—Betamethasone—allergic rhinitis	0.00016	0.000794	CcSEcCtD
Gefitinib—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.00016	0.000794	CcSEcCtD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000158	0.00322	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	0.000157	0.00322	CbGpPWpGaD
Gefitinib—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.000156	0.000776	CcSEcCtD
Gefitinib—Anorexia—Dexamethasone—allergic rhinitis	0.000155	0.000773	CcSEcCtD
Gefitinib—Anorexia—Betamethasone—allergic rhinitis	0.000155	0.000773	CcSEcCtD
Gefitinib—Urticaria—Prednisolone—allergic rhinitis	0.000155	0.000772	CcSEcCtD
Gefitinib—Fatigue—Triamcinolone—allergic rhinitis	0.000155	0.000771	CcSEcCtD
Gefitinib—Fatigue—Methylprednisolone—allergic rhinitis	0.000155	0.000769	CcSEcCtD
Gefitinib—Pain—Triamcinolone—allergic rhinitis	0.000154	0.000764	CcSEcCtD
Gefitinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	0.000153	0.00313	CbGpPWpGaD
Gefitinib—Hypotension—Betamethasone—allergic rhinitis	0.000152	0.000758	CcSEcCtD
Gefitinib—Hypotension—Dexamethasone—allergic rhinitis	0.000152	0.000758	CcSEcCtD
Gefitinib—Urticaria—Hydrocortisone—allergic rhinitis	0.000152	0.000754	CcSEcCtD
Gefitinib—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000151	0.00075	CcSEcCtD
Gefitinib—Abdominal pain—Hydrocortisone—allergic rhinitis	0.000151	0.00075	CcSEcCtD
Gefitinib—IRAK1—p75 NTR receptor-mediated signalling—NFKB1—allergic rhinitis	0.000151	0.00308	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—IL4—allergic rhinitis	0.00015	0.00306	CbGpPWpGaD
Gefitinib—IRAK4—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	0.000149	0.00304	CbGpPWpGaD
Gefitinib—IRAK4—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	0.000147	0.00301	CbGpPWpGaD
Gefitinib—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	0.000147	0.000729	CcSEcCtD
Gefitinib—ABCB1—Allograft Rejection—IL5—allergic rhinitis	0.000146	0.00299	CbGpPWpGaD
Gefitinib—IRAK1—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000146	0.00299	CbGpPWpGaD
Gefitinib—CYP1A1—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.000146	0.00299	CbGpPWpGaD
Gefitinib—IRAK1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	0.000145	0.00296	CbGpPWpGaD
Gefitinib—Hypersensitivity—Prednisolone—allergic rhinitis	0.000144	0.000716	CcSEcCtD
Gefitinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—allergic rhinitis	0.000143	0.00293	CbGpPWpGaD
Gefitinib—MKNK1—MAPK Signaling Pathway—TGFB1—allergic rhinitis	0.000143	0.00293	CbGpPWpGaD
Gefitinib—Urticaria—Triamcinolone—allergic rhinitis	0.000143	0.00071	CcSEcCtD
Gefitinib—Urticaria—Methylprednisolone—allergic rhinitis	0.000142	0.000709	CcSEcCtD
Gefitinib—IRAK1—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	0.000142	0.00291	CbGpPWpGaD
Gefitinib—CYP1A1—Oxidative Stress—NFKB1—allergic rhinitis	0.000142	0.00291	CbGpPWpGaD
Gefitinib—Body temperature increased—Triamcinolone—allergic rhinitis	0.000142	0.000707	CcSEcCtD
Gefitinib—ERBB3—Immune System—MS4A2—allergic rhinitis	0.000142	0.0029	CbGpPWpGaD
Gefitinib—Abdominal pain—Methylprednisolone—allergic rhinitis	0.000142	0.000705	CcSEcCtD
Gefitinib—Decreased appetite—Betamethasone—allergic rhinitis	0.000142	0.000705	CcSEcCtD
Gefitinib—Decreased appetite—Dexamethasone—allergic rhinitis	0.000142	0.000705	CcSEcCtD
Gefitinib—CHEK2—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000141	0.00288	CbGpPWpGaD
Gefitinib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000141	0.0007	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000141	0.0007	CcSEcCtD
Gefitinib—Hypersensitivity—Hydrocortisone—allergic rhinitis	0.000141	0.000699	CcSEcCtD
Gefitinib—Fatigue—Betamethasone—allergic rhinitis	0.000141	0.000699	CcSEcCtD
Gefitinib—Fatigue—Dexamethasone—allergic rhinitis	0.000141	0.000699	CcSEcCtD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.00014	0.00286	CbGpPWpGaD
Gefitinib—Pain—Dexamethasone—allergic rhinitis	0.000139	0.000694	CcSEcCtD
Gefitinib—Pain—Betamethasone—allergic rhinitis	0.000139	0.000694	CcSEcCtD
Gefitinib—IRAK1—Apoptosis Modulation and Signaling—NFKB1—allergic rhinitis	0.000139	0.00283	CbGpPWpGaD
Gefitinib—IRAK1—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	0.000137	0.00281	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—IL4—allergic rhinitis	0.000137	0.0028	CbGpPWpGaD
Gefitinib—Asthenia—Hydrocortisone—allergic rhinitis	0.000137	0.000681	CcSEcCtD
Gefitinib—EGFR—Innate Immune System—MS4A2—allergic rhinitis	0.000136	0.00278	CbGpPWpGaD
Gefitinib—Pruritus—Hydrocortisone—allergic rhinitis	0.000135	0.000672	CcSEcCtD
Gefitinib—IRAK1—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000135	0.00276	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000134	0.00274	CbGpPWpGaD
Gefitinib—ALB—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	0.000134	0.00274	CbGpPWpGaD
Gefitinib—Gastrointestinal pain—Betamethasone—allergic rhinitis	0.000133	0.000663	CcSEcCtD
Gefitinib—Gastrointestinal pain—Dexamethasone—allergic rhinitis	0.000133	0.000663	CcSEcCtD
Gefitinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	0.000133	0.00272	CbGpPWpGaD
Gefitinib—Hypersensitivity—Triamcinolone—allergic rhinitis	0.000132	0.000659	CcSEcCtD
Gefitinib—Hypersensitivity—Methylprednisolone—allergic rhinitis	0.000132	0.000657	CcSEcCtD
Gefitinib—MKNK1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000132	0.00269	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—SMAD3—allergic rhinitis	0.000132	0.00269	CbGpPWpGaD
Gefitinib—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000131	0.00065	CcSEcCtD
Gefitinib—Urticaria—Dexamethasone—allergic rhinitis	0.00013	0.000644	CcSEcCtD
Gefitinib—Urticaria—Betamethasone—allergic rhinitis	0.00013	0.000644	CcSEcCtD
Gefitinib—IRAK1—MyD88-independent cascade—NFKB1—allergic rhinitis	0.000129	0.00265	CbGpPWpGaD
Gefitinib—Asthenia—Triamcinolone—allergic rhinitis	0.000129	0.000641	CcSEcCtD
Gefitinib—Abdominal pain—Dexamethasone—allergic rhinitis	0.000129	0.000641	CcSEcCtD
Gefitinib—Body temperature increased—Dexamethasone—allergic rhinitis	0.000129	0.000641	CcSEcCtD
Gefitinib—Body temperature increased—Betamethasone—allergic rhinitis	0.000129	0.000641	CcSEcCtD
Gefitinib—Abdominal pain—Betamethasone—allergic rhinitis	0.000129	0.000641	CcSEcCtD
Gefitinib—Asthenia—Methylprednisolone—allergic rhinitis	0.000129	0.00064	CcSEcCtD
Gefitinib—Pruritus—Triamcinolone—allergic rhinitis	0.000127	0.000632	CcSEcCtD
Gefitinib—Pruritus—Methylprednisolone—allergic rhinitis	0.000127	0.000631	CcSEcCtD
Gefitinib—IRAK1—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000126	0.00259	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—HLA-G—allergic rhinitis	0.000126	0.00259	CbGpPWpGaD
Gefitinib—Rash—Prednisolone—allergic rhinitis	0.000123	0.000613	CcSEcCtD
Gefitinib—Dermatitis—Prednisolone—allergic rhinitis	0.000123	0.000612	CcSEcCtD
Gefitinib—EGFR—LPA receptor mediated events—NFKB1—allergic rhinitis	0.000123	0.00251	CbGpPWpGaD
Gefitinib—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000123	0.00061	CcSEcCtD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.000122	0.00249	CbGpPWpGaD
Gefitinib—Vomiting—Hydrocortisone—allergic rhinitis	0.000121	0.000604	CcSEcCtD
Gefitinib—IRAK1—Signaling by Interleukins—NFKB1—allergic rhinitis	0.000121	0.00247	CbGpPWpGaD
Gefitinib—Rash—Hydrocortisone—allergic rhinitis	0.00012	0.000599	CcSEcCtD
Gefitinib—Dermatitis—Hydrocortisone—allergic rhinitis	0.00012	0.000598	CcSEcCtD
Gefitinib—EGFR—AGE/RAGE pathway—NFKB1—allergic rhinitis	0.00012	0.00245	CbGpPWpGaD
Gefitinib—CYP2C19—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.00012	0.00245	CbGpPWpGaD
Gefitinib—MAP2K5—BDNF signaling pathway—NFKB1—allergic rhinitis	0.00012	0.00245	CbGpPWpGaD
Gefitinib—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.000119	0.00243	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000119	0.00243	CbGpPWpGaD
Gefitinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—NFKB1—allergic rhinitis	0.000118	0.00242	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—MS4A2—allergic rhinitis	0.000118	0.00242	CbGpPWpGaD
Gefitinib—CHEK2—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	0.000117	0.0024	CbGpPWpGaD
Gefitinib—Asthenia—Dexamethasone—allergic rhinitis	0.000117	0.000582	CcSEcCtD
Gefitinib—Asthenia—Betamethasone—allergic rhinitis	0.000117	0.000582	CcSEcCtD
Gefitinib—EGFR—Regulation of Telomerase—NFKB1—allergic rhinitis	0.000117	0.00239	CbGpPWpGaD
Gefitinib—IRAK1—Activated TLR4 signalling—NFKB1—allergic rhinitis	0.000116	0.00238	CbGpPWpGaD
Gefitinib—Nausea—Prednisolone—allergic rhinitis	0.000116	0.000577	CcSEcCtD
Gefitinib—Pruritus—Dexamethasone—allergic rhinitis	0.000115	0.000574	CcSEcCtD
Gefitinib—Pruritus—Betamethasone—allergic rhinitis	0.000115	0.000574	CcSEcCtD
Gefitinib—Vomiting—Triamcinolone—allergic rhinitis	0.000114	0.000568	CcSEcCtD
Gefitinib—Vomiting—Methylprednisolone—allergic rhinitis	0.000114	0.000567	CcSEcCtD
Gefitinib—Nausea—Hydrocortisone—allergic rhinitis	0.000113	0.000564	CcSEcCtD
Gefitinib—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.000113	0.00232	CbGpPWpGaD
Gefitinib—Rash—Triamcinolone—allergic rhinitis	0.000113	0.000564	CcSEcCtD
Gefitinib—Dermatitis—Triamcinolone—allergic rhinitis	0.000113	0.000563	CcSEcCtD
Gefitinib—Rash—Methylprednisolone—allergic rhinitis	0.000113	0.000562	CcSEcCtD
Gefitinib—Dermatitis—Methylprednisolone—allergic rhinitis	0.000113	0.000562	CcSEcCtD
Gefitinib—Diarrhoea—Dexamethasone—allergic rhinitis	0.000112	0.000555	CcSEcCtD
Gefitinib—Diarrhoea—Betamethasone—allergic rhinitis	0.000112	0.000555	CcSEcCtD
Gefitinib—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.00011	0.00225	CbGpPWpGaD
Gefitinib—IRAK1—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	0.00011	0.00224	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—ICAM1—allergic rhinitis	0.000109	0.00223	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—IL10—allergic rhinitis	0.000107	0.00219	CbGpPWpGaD
Gefitinib—Nausea—Triamcinolone—allergic rhinitis	0.000107	0.000531	CcSEcCtD
Gefitinib—Nausea—Methylprednisolone—allergic rhinitis	0.000106	0.00053	CcSEcCtD
Gefitinib—MAP2K5—MAPK Signaling Pathway—NFKB1—allergic rhinitis	0.000106	0.00216	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—IL4—allergic rhinitis	0.000104	0.00213	CbGpPWpGaD
Gefitinib—Vomiting—Dexamethasone—allergic rhinitis	0.000104	0.000516	CcSEcCtD
Gefitinib—Vomiting—Betamethasone—allergic rhinitis	0.000104	0.000516	CcSEcCtD
Gefitinib—MKNK1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000103	0.00211	CbGpPWpGaD
Gefitinib—Rash—Dexamethasone—allergic rhinitis	0.000103	0.000511	CcSEcCtD
Gefitinib—Rash—Betamethasone—allergic rhinitis	0.000103	0.000511	CcSEcCtD
Gefitinib—Dermatitis—Betamethasone—allergic rhinitis	0.000103	0.000511	CcSEcCtD
Gefitinib—Dermatitis—Dexamethasone—allergic rhinitis	0.000103	0.000511	CcSEcCtD
Gefitinib—CSNK1E—Signaling Pathways—PTGDR2—allergic rhinitis	0.000102	0.0021	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000102	0.00209	CbGpPWpGaD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.000101	0.00207	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CCL11—allergic rhinitis	9.98e-05	0.00204	CbGpPWpGaD
Gefitinib—IRAK1—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	9.87e-05	0.00202	CbGpPWpGaD
Gefitinib—ERBB3—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	9.77e-05	0.002	CbGpPWpGaD
Gefitinib—IRAK1—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	9.76e-05	0.002	CbGpPWpGaD
Gefitinib—EGFR—Regulation of Telomerase—TGFB1—allergic rhinitis	9.74e-05	0.00199	CbGpPWpGaD
Gefitinib—Nausea—Betamethasone—allergic rhinitis	9.68e-05	0.000482	CcSEcCtD
Gefitinib—Nausea—Dexamethasone—allergic rhinitis	9.68e-05	0.000482	CcSEcCtD
Gefitinib—IRAK4—Immune System—HLA-G—allergic rhinitis	9.62e-05	0.00197	CbGpPWpGaD
Gefitinib—ERBB3—B Cell Activation—NFKB1—allergic rhinitis	9.04e-05	0.00185	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	8.9e-05	0.00182	CbGpPWpGaD
Gefitinib—MAP2K5—MAPK Signaling Pathway—TGFB1—allergic rhinitis	8.8e-05	0.0018	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—ICAM1—allergic rhinitis	8.66e-05	0.00177	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	8.49e-05	0.00174	CbGpPWpGaD
Gefitinib—ALB—Vitamin B12 Metabolism—NFKB1—allergic rhinitis	8.48e-05	0.00173	CbGpPWpGaD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	8.41e-05	0.00172	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—PTGDR2—allergic rhinitis	8.1e-05	0.00166	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CYSLTR1—allergic rhinitis	8.04e-05	0.00164	CbGpPWpGaD
Gefitinib—EGFR—Immune System—MS4A2—allergic rhinitis	7.9e-05	0.00162	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—HLA-DQB1—allergic rhinitis	7.89e-05	0.00161	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—PTGDR2—allergic rhinitis	7.81e-05	0.0016	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CCL11—allergic rhinitis	7.76e-05	0.00159	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL5—allergic rhinitis	7.75e-05	0.00159	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—HLA-G—allergic rhinitis	7.67e-05	0.00157	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—PTGDR2—allergic rhinitis	7.36e-05	0.0015	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	7.33e-05	0.0015	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TAC1—allergic rhinitis	7.25e-05	0.00148	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—HLA-G—allergic rhinitis	7.04e-05	0.00144	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—NFKB1—allergic rhinitis	6.91e-05	0.00141	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—NFKB1—allergic rhinitis	6.9e-05	0.00141	CbGpPWpGaD
Gefitinib—MKNK1—Disease—SMAD3—allergic rhinitis	6.78e-05	0.00139	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL5—allergic rhinitis	6.74e-05	0.00138	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—NFKB1—allergic rhinitis	6.69e-05	0.00137	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—NFKB1—allergic rhinitis	6.66e-05	0.00136	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—PTGDR2—allergic rhinitis	6.5e-05	0.00133	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—ADIPOQ—allergic rhinitis	6.48e-05	0.00132	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HLA-G—allergic rhinitis	6.38e-05	0.00131	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CYSLTR1—allergic rhinitis	6.35e-05	0.0013	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—TGFB1—allergic rhinitis	6.27e-05	0.00128	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL5—allergic rhinitis	6.18e-05	0.00126	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	6.18e-05	0.00126	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCL11—allergic rhinitis	6.14e-05	0.00126	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CYSLTR1—allergic rhinitis	6.13e-05	0.00125	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—HLA-DQB1—allergic rhinitis	6e-05	0.00123	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCL11—allergic rhinitis	5.92e-05	0.00121	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.77e-05	0.00118	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—ICAM1—allergic rhinitis	5.76e-05	0.00118	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	5.7e-05	0.00117	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—NFKB1—allergic rhinitis	5.67e-05	0.00116	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TAC1—allergic rhinitis	5.64e-05	0.00115	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	5.64e-05	0.00115	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCL11—allergic rhinitis	5.57e-05	0.00114	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—TGFB1—allergic rhinitis	5.57e-05	0.00114	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—NFKB1—allergic rhinitis	5.54e-05	0.00113	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—CD4—allergic rhinitis	5.53e-05	0.00113	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—NFKB1—allergic rhinitis	5.48e-05	0.00112	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	5.44e-05	0.00111	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—SMAD3—allergic rhinitis	5.27e-05	0.00108	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL5—allergic rhinitis	5.24e-05	0.00107	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL5—allergic rhinitis	5.15e-05	0.00105	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	5.12e-05	0.00105	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CYSLTR1—allergic rhinitis	5.1e-05	0.00104	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—NFKB1—allergic rhinitis	5.03e-05	0.00103	CbGpPWpGaD
Gefitinib—ALB—Platelet degranulation—TGFB1—allergic rhinitis	4.93e-05	0.00101	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCL11—allergic rhinitis	4.93e-05	0.00101	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—HLA-DQB1—allergic rhinitis	4.79e-05	0.000979	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—NFKB1—allergic rhinitis	4.76e-05	0.000974	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—SMAD3—allergic rhinitis	4.75e-05	0.000971	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TGFB1—allergic rhinitis	4.72e-05	0.000966	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—SMAD3—allergic rhinitis	4.71e-05	0.000963	CbGpPWpGaD
Gefitinib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	4.69e-05	0.00096	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TAC1—allergic rhinitis	4.46e-05	0.000912	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—CD4—allergic rhinitis	4.41e-05	0.000901	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—HLA-DQB1—allergic rhinitis	4.39e-05	0.000898	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—ICAM1—allergic rhinitis	4.38e-05	0.000896	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	4.36e-05	0.000892	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PTGDR2—allergic rhinitis	4.35e-05	0.000889	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TAC1—allergic rhinitis	4.3e-05	0.000879	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-G—allergic rhinitis	4.27e-05	0.000873	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	4.26e-05	0.000872	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—CD4—allergic rhinitis	4.23e-05	0.000865	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL5—allergic rhinitis	4.15e-05	0.000848	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—TAC1—allergic rhinitis	4.05e-05	0.000828	CbGpPWpGaD
Gefitinib—ERBB3—Disease—SMAD3—allergic rhinitis	4.02e-05	0.000821	CbGpPWpGaD
Gefitinib—MKNK1—Disease—CD4—allergic rhinitis	4e-05	0.000818	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL5—allergic rhinitis	4e-05	0.000817	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HLA-DQB1—allergic rhinitis	3.98e-05	0.000815	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—NFKB1—allergic rhinitis	3.8e-05	0.000776	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IL5—allergic rhinitis	3.78e-05	0.000773	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL5—allergic rhinitis	3.77e-05	0.00077	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—NFKB1—allergic rhinitis	3.71e-05	0.000758	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—SMAD3—allergic rhinitis	3.69e-05	0.000755	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—CD4—allergic rhinitis	3.67e-05	0.00075	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—NFKB1—allergic rhinitis	3.65e-05	0.000746	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TAC1—allergic rhinitis	3.58e-05	0.000732	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—ICAM1—allergic rhinitis	3.49e-05	0.000714	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL5—allergic rhinitis	3.44e-05	0.000704	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CYSLTR1—allergic rhinitis	3.41e-05	0.000697	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL5—allergic rhinitis	3.33e-05	0.00068	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL11—allergic rhinitis	3.29e-05	0.000674	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CD4—allergic rhinitis	3.22e-05	0.000658	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—ICAM1—allergic rhinitis	3.21e-05	0.000656	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—NFKB1—allergic rhinitis	3.16e-05	0.000646	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—CD4—allergic rhinitis	3.11e-05	0.000636	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—SMAD3—allergic rhinitis	2.92e-05	0.000597	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—ICAM1—allergic rhinitis	2.91e-05	0.000595	CbGpPWpGaD
Gefitinib—MKNK1—Disease—TGFB1—allergic rhinitis	2.87e-05	0.000587	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—SMAD3—allergic rhinitis	2.81e-05	0.000575	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—NFKB1—allergic rhinitis	2.77e-05	0.000567	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-DQB1—allergic rhinitis	2.66e-05	0.000545	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.58e-05	0.000528	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD4—allergic rhinitis	2.57e-05	0.000525	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CD4—allergic rhinitis	2.45e-05	0.000502	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NFKB1—allergic rhinitis	2.41e-05	0.000493	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—NFKB1—allergic rhinitis	2.39e-05	0.000489	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TAC1—allergic rhinitis	2.39e-05	0.000489	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CD4—allergic rhinitis	2.37e-05	0.000485	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD4—allergic rhinitis	2.36e-05	0.000482	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—SMAD3—allergic rhinitis	2.34e-05	0.000479	CbGpPWpGaD
Gefitinib—EGFR—Disease—SMAD3—allergic rhinitis	2.24e-05	0.000457	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—TGFB1—allergic rhinitis	2.23e-05	0.000456	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL5—allergic rhinitis	2.22e-05	0.000455	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—NFKB1—allergic rhinitis	2.21e-05	0.000452	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	2.19e-05	0.000447	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.15e-05	0.00044	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD4—allergic rhinitis	2.14e-05	0.000437	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—NFKB1—allergic rhinitis	2.11e-05	0.000432	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—NFKB1—allergic rhinitis	2.03e-05	0.000415	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TGFB1—allergic rhinitis	2.01e-05	0.000411	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TGFB1—allergic rhinitis	1.99e-05	0.000408	CbGpPWpGaD
Gefitinib—EGFR—Immune System—ICAM1—allergic rhinitis	1.94e-05	0.000398	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NFKB1—allergic rhinitis	1.88e-05	0.000384	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—NFKB1—allergic rhinitis	1.84e-05	0.000376	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TGFB1—allergic rhinitis	1.7e-05	0.000348	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SMAD3—allergic rhinitis	1.57e-05	0.00032	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TGFB1—allergic rhinitis	1.56e-05	0.00032	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NFKB1—allergic rhinitis	1.48e-05	0.000303	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NFKB1—allergic rhinitis	1.43e-05	0.000292	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD4—allergic rhinitis	1.43e-05	0.000292	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD4—allergic rhinitis	1.32e-05	0.00027	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TGFB1—allergic rhinitis	1.24e-05	0.000253	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NFKB1—allergic rhinitis	1.23e-05	0.000252	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TGFB1—allergic rhinitis	1.19e-05	0.000244	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NFKB1—allergic rhinitis	1.19e-05	0.000243	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TGFB1—allergic rhinitis	1.13e-05	0.00023	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TGFB1—allergic rhinitis	9.91e-06	0.000203	CbGpPWpGaD
Gefitinib—EGFR—Disease—TGFB1—allergic rhinitis	9.47e-06	0.000194	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NFKB1—allergic rhinitis	7.96e-06	0.000163	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TGFB1—allergic rhinitis	6.63e-06	0.000136	CbGpPWpGaD
